AAPL332.35+1.01 (+0.30%) ▲|ABBV262.25-0.80 (-0.30%) ▼|ABT103.15+1.12 (+1.09%) ▲|ACN190.37-3.03 (-1.57%) ▼|ADBE250.91-6.85 (-2.66%) ▼|AMAT423.30+2.13 (+0.51%) ▲|AMD522.37+18.17 (+3.60%) ▲|AMGN376.85+1.20 (+0.32%) ▲|AMT179.31+1.60 (+0.90%) ▲|AMZN247.56-0.86 (-0.35%) ▼|AVGO342.41+3.14 (+0.92%) ▲|AXP317.11-7.32 (-2.26%) ▼|BA211.22+1.53 (+0.73%) ▲|BAC58.44-1.09 (-1.82%) ▼|BKNG173.13+1.81 (+1.06%) ▲|BLK1,047.95-10.71 (-1.01%) ▼|BMY64.15+0.42 (+0.66%) ▲|BNY155.09+0.42 (+0.27%) ▲|BRK-B520.53+3.77 (+0.73%) ▲|C135.17-1.00 (-0.73%) ▼|CAT791.36+7.82 (+1.00%) ▲|CL87.33+0.33 (+0.37%) ▲|CMCSA24.18-0.24 (-0.98%) ▼|COF206.80-0.05 (-0.02%) ▼|COP134.69-6.54 (-4.63%) ▼|COST901.54+0.19 (+0.02%) ▲|CRM250.90-4.76 (-1.86%) ▼|CSCO110.66+0.59 (+0.54%) ▲|CVS93.69-0.80 (-0.85%) ▼|CVX212.36-5.41 (-2.48%) ▼|DE674.73-9.31 (-1.36%) ▼|DHR208.10-1.27 (-0.60%) ▼|DIS107.86+1.44 (+1.35%) ▲|DUK118.65+0.88 (+0.75%) ▲|EMR148.64+1.64 (+1.12%) ▲|FDX302.91-5.35 (-1.74%) ▼|GD361.16+2.56 (+0.71%) ▲|GE317.05+10.00 (+3.26%) ▲|GEV931.29+48.48 (+5.49%) ▲|GILD148.93+2.63 (+1.79%) ▲|GM84.34-1.04 (-1.21%) ▼|GOOG342.27+0.84 (+0.25%) ▲|GOOGL345.68+0.70 (+0.20%) ▲|GS977.03+0.36 (+0.04%) ▲|HD307.77+2.29 (+0.75%) ▲|HON209.04+5.60 (+2.75%) ▲|IBM241.16-7.21 (-2.90%) ▼|INTC102.07+4.93 (+5.07%) ▲|INTU322.28-7.00 (-2.12%) ▼|ISRG386.36+9.20 (+2.44%) ▲|JNJ268.04+0.84 (+0.31%) ▲|JPM350.24-2.25 (-0.64%) ▼|KO88.43-0.28 (-0.32%) ▼|LIN465.08+2.12 (+0.46%) ▲|LLY1,144.80+8.69 (+0.76%) ▲|LMT538.64+5.18 (+0.97%) ▲|LOW196.36+1.75 (+0.90%) ▲|LRCX273.66+2.79 (+1.03%) ▲|MA570.34-2.93 (-0.51%) ▼|MCD250.76-2.02 (-0.80%) ▼|MDLZ62.60+0.50 (+0.81%) ▲|MDT94.37+0.62 (+0.66%) ▲|META677.37+7.13 (+1.06%) ▲|MMM162.64-2.03 (-1.23%) ▼|MO70.51+0.70 (+1.00%) ▲|MRK144.08+0.29 (+0.20%) ▲|MS206.86+0.58 (+0.28%) ▲|MSFT493.86-3.27 (-0.66%) ▼|MU928.86+1.26 (+0.14%) ▲|NEE81.24+0.17 (+0.20%) ▲|NFLX77.26-0.65 (-0.83%) ▼|NKE36.33+0.11 (+0.29%) ▲|NOW140.63-1.27 (-0.90%) ▼|NVDA216.18+4.01 (+1.89%) ▲|ORCL143.92+3.57 (+2.54%) ▲|PEP135.24-0.26 (-0.19%) ▼|PFE27.60+0.05 (+0.16%) ▲|PG147.89+1.22 (+0.83%) ▲|PLTR171.70-0.86 (-0.50%) ▼|PM194.01-0.11 (-0.05%) ▼|QCOM189.10+1.30 (+0.69%) ▲|RTX197.33+1.83 (+0.94%) ▲|SBUX97.95+1.37 (+1.42%) ▲|SCHW106.05-1.74 (-1.61%) ▼|SO86.66+0.71 (+0.82%) ▲|SPG204.50+0.40 (+0.20%) ▲|T26.36-0.37 (-1.37%) ▼|TMO643.94+2.55 (+0.40%) ▲|TMUS178.87-1.60 (-0.89%) ▼|TSLA361.86+5.28 (+1.48%) ▲|TXN265.23+1.80 (+0.68%) ▲|UBER71.31-0.13 (-0.18%) ▼|UNH379.32+3.39 (+0.90%) ▲|UNP285.46+1.47 (+0.52%) ▲|UPS99.79-2.56 (-2.50%) ▼|USB60.90-1.33 (-2.13%) ▼|V371.61-4.02 (-1.07%) ▼|VZ50.62-0.84 (-1.62%) ▼|WFC88.49-1.24 (-1.38%) ▼|WMT108.41+0.32 (+0.29%) ▲|XOM164.13-5.19 (-3.07%) ▼|AAPL332.35+1.01 (+0.30%) ▲|ABBV262.25-0.80 (-0.30%) ▼|ABT103.15+1.12 (+1.09%) ▲|ACN190.37-3.03 (-1.57%) ▼|ADBE250.91-6.85 (-2.66%) ▼|AMAT423.30+2.13 (+0.51%) ▲|AMD522.37+18.17 (+3.60%) ▲|AMGN376.85+1.20 (+0.32%) ▲|AMT179.31+1.60 (+0.90%) ▲|AMZN247.56-0.86 (-0.35%) ▼|AVGO342.41+3.14 (+0.92%) ▲|AXP317.11-7.32 (-2.26%) ▼|BA211.22+1.53 (+0.73%) ▲|BAC58.44-1.09 (-1.82%) ▼|BKNG173.13+1.81 (+1.06%) ▲|BLK1,047.95-10.71 (-1.01%) ▼|BMY64.15+0.42 (+0.66%) ▲|BNY155.09+0.42 (+0.27%) ▲|BRK-B520.53+3.77 (+0.73%) ▲|C135.17-1.00 (-0.73%) ▼|CAT791.36+7.82 (+1.00%) ▲|CL87.33+0.33 (+0.37%) ▲|CMCSA24.18-0.24 (-0.98%) ▼|COF206.80-0.05 (-0.02%) ▼|COP134.69-6.54 (-4.63%) ▼|COST901.54+0.19 (+0.02%) ▲|CRM250.90-4.76 (-1.86%) ▼|CSCO110.66+0.59 (+0.54%) ▲|CVS93.69-0.80 (-0.85%) ▼|CVX212.36-5.41 (-2.48%) ▼|DE674.73-9.31 (-1.36%) ▼|DHR208.10-1.27 (-0.60%) ▼|DIS107.86+1.44 (+1.35%) ▲|DUK118.65+0.88 (+0.75%) ▲|EMR148.64+1.64 (+1.12%) ▲|FDX302.91-5.35 (-1.74%) ▼|GD361.16+2.56 (+0.71%) ▲|GE317.05+10.00 (+3.26%) ▲|GEV931.29+48.48 (+5.49%) ▲|GILD148.93+2.63 (+1.79%) ▲|GM84.34-1.04 (-1.21%) ▼|GOOG342.27+0.84 (+0.25%) ▲|GOOGL345.68+0.70 (+0.20%) ▲|GS977.03+0.36 (+0.04%) ▲|HD307.77+2.29 (+0.75%) ▲|HON209.04+5.60 (+2.75%) ▲|IBM241.16-7.21 (-2.90%) ▼|INTC102.07+4.93 (+5.07%) ▲|INTU322.28-7.00 (-2.12%) ▼|ISRG386.36+9.20 (+2.44%) ▲|JNJ268.04+0.84 (+0.31%) ▲|JPM350.24-2.25 (-0.64%) ▼|KO88.43-0.28 (-0.32%) ▼|LIN465.08+2.12 (+0.46%) ▲|LLY1,144.80+8.69 (+0.76%) ▲|LMT538.64+5.18 (+0.97%) ▲|LOW196.36+1.75 (+0.90%) ▲|LRCX273.66+2.79 (+1.03%) ▲|MA570.34-2.93 (-0.51%) ▼|MCD250.76-2.02 (-0.80%) ▼|MDLZ62.60+0.50 (+0.81%) ▲|MDT94.37+0.62 (+0.66%) ▲|META677.37+7.13 (+1.06%) ▲|MMM162.64-2.03 (-1.23%) ▼|MO70.51+0.70 (+1.00%) ▲|MRK144.08+0.29 (+0.20%) ▲|MS206.86+0.58 (+0.28%) ▲|MSFT493.86-3.27 (-0.66%) ▼|MU928.86+1.26 (+0.14%) ▲|NEE81.24+0.17 (+0.20%) ▲|NFLX77.26-0.65 (-0.83%) ▼|NKE36.33+0.11 (+0.29%) ▲|NOW140.63-1.27 (-0.90%) ▼|NVDA216.18+4.01 (+1.89%) ▲|ORCL143.92+3.57 (+2.54%) ▲|PEP135.24-0.26 (-0.19%) ▼|PFE27.60+0.05 (+0.16%) ▲|PG147.89+1.22 (+0.83%) ▲|PLTR171.70-0.86 (-0.50%) ▼|PM194.01-0.11 (-0.05%) ▼|QCOM189.10+1.30 (+0.69%) ▲|RTX197.33+1.83 (+0.94%) ▲|SBUX97.95+1.37 (+1.42%) ▲|SCHW106.05-1.74 (-1.61%) ▼|SO86.66+0.71 (+0.82%) ▲|SPG204.50+0.40 (+0.20%) ▲|T26.36-0.37 (-1.37%) ▼|TMO643.94+2.55 (+0.40%) ▲|TMUS178.87-1.60 (-0.89%) ▼|TSLA361.86+5.28 (+1.48%) ▲|TXN265.23+1.80 (+0.68%) ▲|UBER71.31-0.13 (-0.18%) ▼|UNH379.32+3.39 (+0.90%) ▲|UNP285.46+1.47 (+0.52%) ▲|UPS99.79-2.56 (-2.50%) ▼|USB60.90-1.33 (-2.13%) ▼|V371.61-4.02 (-1.07%) ▼|VZ50.62-0.84 (-1.62%) ▼|WFC88.49-1.24 (-1.38%) ▼|WMT108.41+0.32 (+0.29%) ▲|XOM164.13-5.19 (-3.07%) ▼|
22.5 C
New York
Wednesday, September 16, 2026

Tag: news

newssourceFORcompanyinformationcontent1releasesmarket

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026

Basel, June 8th, 2026 – Novartis will present data from 10 abstracts at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026, spanning Rhapsido®  (remibrutinib) clinical trial results and real-world evidence on patient burden and treatment experience. Highlights include two late-breaking oral presentations; the Phase III RemIND trial for Rhapsido in chronic inducible urticaria (CIndU) and extension data from the Phase IIIb REMIXED trial in chronic spontaneous urticaria (CSU).

“The Rhapsido presentations at EAACI 2026 expand our understanding of BTK inhibition across multiple immune-mediated diseases and provide evidence of its potential to make a meaningful impact for patients who continue to face significant burden and limited treatment options,” said Angelika Jahreis, Global Head, Immunology Development, Novartis. “Novartis will present Rhapsido data from a long-term extension trial in chronic spontaneous urticaria, Phase III data in three types of chronic inducible urticaria, and early Phase II dose-response analysis for food allergy – together providing scientific evidence for its impact across numerous diseases.”

Abstracts accepted by EAACI include: 

onsemi Introduces Industry-First Elite Pairing Studio to Simplify Power Design

Interactive simulation tool gives engineers visibility into device level behavior and pairing trade offs, accelerating power electronics design

Millions of students are finishing school this summer. Many still don’t know what’s next.

A Gap Year or Academic Year abroad is far more than a year off, it's an opportunity for young people to gain life experience and improve language skills.

Telenor receives approval to acquire GlobalConnect’s consumer business in Norway

The Norwegian Competition Authority has approved Telenor's acquisition of GlobalConnect's Norwegian fibre business for residential customers

Telenor får godkjenning til å kjøpe GlobalConnects fibervirksomhet for privatmarkedet

(Fornebu, 8. juni 2026) Konkurransetilsynet har godkjent Telenors kjøp av GlobalConnects norske fibervirksomhet for privatkunder. Transaksjonen er verdsatt til 6 milliarder kroner og godkjennes på vilkår av avhjelpende tiltak.

Virbac: modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale mixte du 29 juin 2026

Les actionnaires de la société VIRBAC sont invités à participer à l’assemblée générale mixte qui se tiendra le lundi 29 juin 2026 à 14 heures, dans les bâtiments de VIRBAC direction, 13ème rue LID 06517 Carros. 

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Casino Group Communication

Casino Group and the Zouari Family strengthen their historic partnership to accelerate in convenience retail

Realtek Joins OpenTitan Coalition to Develop Discrete Hardware Root of Trust Devices

Realtek Joins OpenTitan Coalition to Develop Discrete Hardware Root of Trust Devices

New Linux Foundation Report Finds AI is Driving Positive Tech Hiring Trends in Europe Amid Growing Security and Skills Gaps

Increased AI deployment results in an aggregated net hiring effect of +27% expected in 2026, while upskilling internal talent emerges as the primary strategy...

Classico Pokemon Collection: “Stay with Your Favorite Pokemon Everywhere”

TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian...

Arrivia and KrisFlyer Expand Partnership to Launch Cruise Redemptions with Miles

SINGAPORE, June 8, 2026 /PRNewswire/ -- arrivia and KrisFlyer, the lifestyle rewards programme of the Singapore Airlines Group, are elevating member benefits with the...

FLSmidth: Transactions under share buy-back programme

COMPANY ANNOUNCEMENT NO. 29-2026
FLSmidth & Co. A/S
8 June 2026
Copenhagen, Denmark

TGS Acquires Apparition Geoservices to Deliver a Step-Change in Seismic Efficiency and Subsurface Imaging

TGS Acquires Apparition Geoservices to Deliver a Step-Change in Seismic Efficiency and Subsurface Imaging

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers